Please login to the form below
NHS
This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.
NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
AstraZeneca (AZ) has announced that the National Institute for Health and Care Excellence (NICE) has approved the routine use of Imfinzi (durvalumab) within NHS England as a monotherapy to treat locally ... Dr Patricia Fisher, consultant clinical
Latest news
-
New NHS prenatal test for rare form of eye cancer
It is the latest example of the NHS harnessing the power of genomics to diagnose and treat patients more effectively. ... The new NHS test – developed at Birmingham Women’s and Children’s NHS Foundation Trust – identifies those at risk of
-
New study highlights significance of chronic obstructive pulmonary disease flare-ups
COPD causes nearly 30, 000 deaths in England each year, with an annual overall cost to the NHS of £1.9bn. ... This places a significant overall burden on the NHS, with a cost to the healthcare system of £1.9bn a year.
-
NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan
NHS England, the National Institute for Health and Care Excellence (NICE) and the UK Department of Health have concluded an assessment of Pfizer’s Zavicefta (ceftazidime with avibactam) and Shionogi’s ... This sum is based on the value they offer the
-
AbbVie’s Rinvoq accepted by SMC for atopic dermatitis
Scotland is the first nation in the UK to approve NHS access for the drug. ... unsuitable. The decision makes Scotland the first nation in the UK to be able to give access to Rinvoq via the NHS, for people suffering with moderate to severe eczema.
-
Amgen and UCB’s Evenity recommended by NICE for severe osteoporosis
Amgen and UCB’s Evenity (romosozumab) has been recommended for use by the NHS in England and Wales by the National Institute for Health and Care Excellence (NICE). ... new treatment contributes to easing NHS pressures.”.
More from news
Approximately 386 fully matching, plus 1,837 partially matching documents found.
Latest Intelligence
-
Listen, learn and lift off
tested outcomes that reduce any additional workload for the NHS.
-
Value add: using digital engagement metrics to optimise and drive salesforce effectiveness
By Simon Grime
-
Mapping patient pathways – with a focus on patient-centricity
The findings from our first panel indicated that there is still some way to go to achieve the ultimate ambition of today’s NHS – positioning all patients as equal partners in ... Digital transformation: With the £2.1bn recently pledged to digitally
-
Patient-centricity and how HCPs can help achieve better patient outcomes through collaboration
1. Tackling the electives backlog. 2. Putting the NHS back on a sustainable footing. ... The roll out of the NHS app has allowed patients to access their own GP records and view test results as soon as they are available.
-
Should we stop talking about people as patients and start thinking of them as partners? After all, it is their physical and mental health and well-being
The Organisation for the Review of Care and Health Applications (ORCHA) is now a global organisation working with 70% of NHS organisations in the UK to recommend safe and effective mHealth
More from intelligence
Approximately 34 fully matching, plus 204 partially matching documents found.
Latest appointments
-
Amanda Pritchard becomes NHS England’s first female chief executive
She first joined the NHS as a graduate management trainee in 1997 after graduating from Oxford University. ... She has held a variety of additional NHS management positions over the course of her career.
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer. ... of Health and Social Care, Office for Life Sciences, London Borough of
-
COUCH Health taps Mark Duman for chief strategy officer role
He has over 30 years of experience working in the healthcare/pharmaceutical industries, having worked with clients including AstraZeneca, the Department of Health, Johnson &Johnson, NHS England, Novartis, Roche Diagnostics and
-
Doina Ionescu elected to ABPI’s board of directors
Ionescu will represent medium-sized companies on the ABPI board of directors, with aims of further strengthening the relationship between the pharma industry, patients, the NHS and the UK economy.
-
Diane DiGangi Trench appointed as country head of Sandoz UK
Sandoz is a purpose-driven organisation and we are proud to support the NHS with our generic, biosimilar and originator medicines,” she added.
More from appointments
Approximately 18 fully matching, plus 95 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
18. The product was such a success that it is now offered to affected women via the NHS. ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence needed before NHS can adopt use of contraception app.
-
Food Allergy – Is avoidance the only option?
References. NHS. Food allergy. ... Accessed April 27, 2022. NHS. Food intolerance.
-
UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS
This adds further new angles to what the NHS customer regards as “good value”. ... reinvigorate the disease-specific service improvement aspirations in the NHS Long Term Plan, for example?
-
Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool
We know ‘who’s who’ in the new NHS landscape and what their priorities and focus are better than anyone. ... social deprivation to help Industry work with NHS customers to tackle health inequalities and improve population health across care pathways
-
How marketers are balancing the changing trends in women's health
The device was a massive success, revolutionising compliance for pelvic floor exercises compared to it’s predecessors and is now even used by the NHS. ... Accessed March 1, 2022. Elvie. Elvie and the NHS.
More from PMHub
Approximately 53 fully matching, plus 260 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- Scientists discover new approach to treat brain tumours
- Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Assessing the value of interim analyses in clinical trials
- Taking a holistic approach to patient care
- Almirall and Evotec team up in multi-target dermatology alliance
- Moderna wins Prix Galien UK Award for best biotechnology product
- Why testing shouldn't be confined to the lab
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Live Webinar: Engaging Patients "Just-In-Time" with Machine Learning
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- Roche shares new positive Ocrevus data for MS patients
- How scientific storytelling can help Pharma cut through the noise
- Almirall and Evotec team up in multi-target dermatology alliance
- Christian Schade joins Aprea AB
- FDA approves Alexion’s Ultomiris for generalised myasthenia gravis
- First Herceptin biosimilar cleared in Europe
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
